FI956334A0 - Farmakologiskt aktiva enantiomerer - Google Patents

Farmakologiskt aktiva enantiomerer

Info

Publication number
FI956334A0
FI956334A0 FI956334A FI956334A FI956334A0 FI 956334 A0 FI956334 A0 FI 956334A0 FI 956334 A FI956334 A FI 956334A FI 956334 A FI956334 A FI 956334A FI 956334 A0 FI956334 A0 FI 956334A0
Authority
FI
Finland
Prior art keywords
pharmacologically active
active enantiomers
enantiomers
alk
enantiomer
Prior art date
Application number
FI956334A
Other languages
English (en)
Finnish (fi)
Other versions
FI111943B (sv
FI956334A (sv
Inventor
Leandro Baiocchi
Valerio Cioli
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of FI956334A0 publication Critical patent/FI956334A0/sv
Publication of FI956334A publication Critical patent/FI956334A/sv
Application granted granted Critical
Publication of FI111943B publication Critical patent/FI111943B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI956334A 1993-07-01 1995-12-29 Analogiförfarande för framställning av en terapeutiskt användbar enantiomer förening, som är (S)- eller (R)-2-[3[4-(3-klorfenyl)-1-(2-alkyl)-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3-(2H)-on,och mellanprodukter FI111943B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT93MI001418A IT1268414B1 (it) 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi
ITMI931418 1993-07-01
EP9402061 1994-06-21
PCT/EP1994/002061 WO1995001354A1 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers

Publications (3)

Publication Number Publication Date
FI956334A0 true FI956334A0 (sv) 1995-12-29
FI956334A FI956334A (sv) 1996-02-19
FI111943B FI111943B (sv) 2003-10-15

Family

ID=11366510

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956334A FI111943B (sv) 1993-07-01 1995-12-29 Analogiförfarande för framställning av en terapeutiskt användbar enantiomer förening, som är (S)- eller (R)-2-[3[4-(3-klorfenyl)-1-(2-alkyl)-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3-(2H)-on,och mellanprodukter

Country Status (30)

Country Link
US (3) US5741907A (sv)
EP (1) EP0707587B1 (sv)
JP (1) JP3096065B2 (sv)
KR (1) KR100306018B1 (sv)
CN (3) CN1046281C (sv)
AT (1) ATE158796T1 (sv)
AU (1) AU689478B2 (sv)
BG (1) BG61815B1 (sv)
BR (1) BR9406996A (sv)
CA (1) CA2166470C (sv)
CZ (1) CZ289526B6 (sv)
DE (1) DE69405999T2 (sv)
DK (1) DK0707587T3 (sv)
ES (1) ES2111309T3 (sv)
FI (1) FI111943B (sv)
GE (1) GEP19991791B (sv)
GR (1) GR3025806T3 (sv)
HK (2) HK1018781A1 (sv)
HU (1) HU221631B1 (sv)
IT (1) IT1268414B1 (sv)
LV (1) LV11546B (sv)
NO (1) NO305957B1 (sv)
NZ (1) NZ268014A (sv)
PL (1) PL181831B1 (sv)
RO (2) RO121031B1 (sv)
RU (1) RU2128180C1 (sv)
SK (1) SK281060B6 (sv)
UA (1) UA53607C2 (sv)
WO (1) WO1995001354A1 (sv)
ZA (1) ZA944570B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
JP2009018992A (ja) * 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
RU2706700C1 (ru) 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365453A (en) * 1963-10-28 1968-01-23 Sterling Drug Inc 1-phenyl-4-lower-alkyl-2-piperazinones
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US5303837A (en) * 1991-03-05 1994-04-19 Portola Packaging, Inc. One-piece fitment and plug with tamper-evident band
US5739334A (en) * 1992-01-17 1998-04-14 Istituto Ricerca Francesco Angelini S.P.A. Alkyl derivatives of trazodone with CNS activity
IT1258790B (it) * 1992-01-17 1996-02-29 Angelini Francesco Ist Ricerca Alchil derivati del trazodone
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol

Also Published As

Publication number Publication date
RO116899B1 (ro) 2001-07-30
EP0707587A1 (en) 1996-04-24
BG100331A (bg) 1996-09-30
UA53607C2 (uk) 2003-02-17
EP0707587B1 (en) 1997-10-01
FI111943B (sv) 2003-10-15
CZ289526B6 (cs) 2002-02-13
LV11546B (en) 1997-02-20
JP3096065B2 (ja) 2000-10-10
SK281060B6 (sk) 2000-11-07
PL181831B1 (pl) 2001-09-28
GEP19991791B (en) 1999-10-05
AU689478B2 (en) 1998-04-02
CN1129939A (zh) 1996-08-28
HUT73230A (en) 1996-07-29
GR3025806T3 (en) 1998-03-31
NO955345L (no) 1996-02-29
RO121031B1 (ro) 2006-11-30
CN1215052A (zh) 1999-04-28
CN1136201C (zh) 2004-01-28
DK0707587T3 (da) 1998-05-11
DE69405999D1 (de) 1997-11-06
SK166495A3 (en) 1996-09-04
IT1268414B1 (it) 1997-02-27
HK1018777A1 (en) 2000-01-07
HK1018781A1 (en) 2000-01-07
ATE158796T1 (de) 1997-10-15
ITMI931418A0 (it) 1993-07-01
BG61815B1 (bg) 1998-06-30
PL312419A1 (en) 1996-04-15
WO1995001354A1 (en) 1995-01-12
ES2111309T3 (es) 1998-03-01
NO955345D0 (no) 1995-12-29
LV11546A (lv) 1996-10-20
FI956334A (sv) 1996-02-19
JPH08512036A (ja) 1996-12-17
CA2166470A1 (en) 1995-01-12
ITMI931418A1 (it) 1995-01-01
KR100306018B1 (ko) 2001-11-30
HU221631B1 (hu) 2002-12-28
NO305957B1 (no) 1999-08-23
US5817815A (en) 1998-10-06
US5973150A (en) 1999-10-26
RU2128180C1 (ru) 1999-03-27
US5741907A (en) 1998-04-21
NZ268014A (en) 1997-08-22
AU7072994A (en) 1995-01-24
CN1136200C (zh) 2004-01-28
CN1215053A (zh) 1999-04-28
BR9406996A (pt) 1996-09-10
HU9503876D0 (en) 1996-02-28
CZ348595A3 (en) 1996-04-17
ZA944570B (en) 1995-04-11
DE69405999T2 (de) 1998-04-16
CA2166470C (en) 2001-12-18
CN1046281C (zh) 1999-11-10

Similar Documents

Publication Publication Date Title
EA199800141A1 (ru) Гетероциклические соединения
KR880000400A (ko) 융합된 사이클릭 아제핀-2-온 유도체 및 그의 제조방법
EP0154234A3 (en) Substituted tyrosil alanine dipeptide amides
DK0707587T3 (da) Farmakologisk aktive enantiomerer
AU586477B2 (en) Hexenoic acids
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
KR890009886A (ko) 심기능 부전의 예방 및 치료제
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.